Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2003 Aug;79(4):286–290. doi: 10.1136/sti.79.4.286

Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka

F Cowan 1, R French 1, P Mayaud 1, R Gopal 1, N Robinson 1, S A de Oliveira 1, T Faillace 1, A Uuskula 1, M Nygard-Kibur 1, S Ramalingam 1, G Sridharan 1, R El Aouad 1, K Alami 1, M Rbai 1, N Sunil-Chandra 1, D Brown 1
PMCID: PMC1744730  PMID: 12902576

Abstract

Background: The association between herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus (HIV) and the development of HSV vaccines have increased interest in the study of HSV epidemiology.

Objectives: To estimate the age and sex specific seroprevalence of HSV-1 and HSV-2 infections in selected populations in Brazil, Estonia, India, Morocco, and Sri Lanka.

Methods: Serum samples were collected from various populations including children, antenatal clinic attenders, blood donors, hospital inpatients, and HIV sentinel surveillance groups. STD clinic attenders were enrolled in Sri Lanka, male military personnel in Morocco. Sera were tested using a common algorithm by type specific HSV-1 and HSV-2 antibody assay.

Results: 13 986 samples were tested, 45.0% from adult females, 32.7% from adult males, and 22.3% from children. The prevalence of HSV-1 varied by site ranging from 78.5%–93.6% in adult males and from 75.5%–97.8% in adult females. In all countries HSV-1 seroprevalence increased significantly with age (p<0.001) in both men and women. The prevalence of HSV-2 infection varied between sites. Brazil had the highest age specific rates of infection for both men and women, followed by Sri Lanka for men and Estonia for women, the lowest rates being found in Estonia for men and India for women. In all countries, HSV-2 seroprevalence increased significantly with age (p<0.01) and adult females had higher rates of infection than adult males by age of infection.

Conclusions: HSV-1 and HSV-2 seroprevalence was consistently higher in women than men, particularly for HSV-2. Population based data on HSV-1 and HSV-2 will be useful for designing potential HSV-2 vaccination strategies and for focusing prevention efforts for HSV-1 and HSV-2 infection.

Full Text

The Full Text of this article is available as a PDF (197.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown Z. A., Selke S., Zeh J., Kopelman J., Maslow A., Ashley R. L., Watts D. H., Berry S., Herd M., Corey L. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997 Aug 21;337(8):509–515. doi: 10.1056/NEJM199708213370801. [DOI] [PubMed] [Google Scholar]
  2. Corey L., Handsfield H. H. Genital herpes and public health: addressing a global problem. JAMA. 2000 Feb 9;283(6):791–794. doi: 10.1001/jama.283.6.791. [DOI] [PubMed] [Google Scholar]
  3. Corey L., Langenberg A. G., Ashley R., Sekulovich R. E., Izu A. E., Douglas J. M., Jr, Handsfield H. H., Warren T., Marr L., Tyring S. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group. JAMA. 1999 Jul 28;282(4):331–340. doi: 10.1001/jama.282.4.331. [DOI] [PubMed] [Google Scholar]
  4. Cowan F. M., Johnson A. M., Ashley R., Corey L., Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ. 1994 Nov 19;309(6965):1325–1329. doi: 10.1136/bmj.309.6965.1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dehne K. L., Pokrovskiy V., Kobyshcha Y., Schwartländer B. Update on the epidemics of HIV and other sexually transmitted infections in the newly independent states of the former Soviet Union. AIDS. 2000;14 (Suppl 3):S75–S84. [PubMed] [Google Scholar]
  6. Gopal R., Gibbs T., Slomka M. J., Whitworth J., Carpenter L. M., Vyse A., Brown D. W. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods. 2000 Jun;87(1-2):71–80. doi: 10.1016/s0166-0934(00)00149-x. [DOI] [PubMed] [Google Scholar]
  7. Kebaabetswe P., Lockman S., Mogwe S., Mandevu R., Thior I., Essex M., Shapiro R. L. Male circumcision: an acceptable strategy for HIV prevention in Botswana. Sex Transm Infect. 2003 Jun;79(3):214–219. doi: 10.1136/sti.79.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Langenberg A. G., Corey L., Ashley R. L., Leong W. P., Straus S. E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med. 1999 Nov 4;341(19):1432–1438. doi: 10.1056/NEJM199911043411904. [DOI] [PubMed] [Google Scholar]
  9. Nahmias A. J., Lee F. K., Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36. [PubMed] [Google Scholar]
  10. Obasi A., Mosha F., Quigley M., Sekirassa Z., Gibbs T., Munguti K., Todd J., Grosskurth H., Mayaud P., Changalucha J. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis. 1999 Jan;179(1):16–24. doi: 10.1086/314555. [DOI] [PubMed] [Google Scholar]
  11. Prince H. E., Ernst C. E., Hogrefe W. R. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies. J Clin Lab Anal. 2000;14(1):13–16. doi: 10.1002/(SICI)1098-2825(2000)14:1&#x0003c;13::AID-JCLA3&#x0003e;3.0.CO;2-C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ross J. D., Smith I. W., Elton R. A. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med. 1993 Oct;69(5):381–383. doi: 10.1136/sti.69.5.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scoular A., Leask B. G., Carrington D. Changing trends in genital herpes due to Herpes simplex virus type 1 in Glasgow, 1985-88. Genitourin Med. 1990 Jun;66(3):226–226. doi: 10.1136/sti.66.3.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Stanberry L. R., Cunningham A. L., Mindel A., Scott L. L., Spruance S. L., Aoki F. Y., Lacey C. J. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis. 2000 Mar;30(3):549–566. doi: 10.1086/313687. [DOI] [PubMed] [Google Scholar]
  15. Turner A. N., Ellertson C., Thomas S., García S. Diagnosis and treatment of presumed STIs at Mexican pharmacies: survey results from a random sample of Mexico City pharmacy attendants. Sex Transm Infect. 2003 Jun;79(3):224–228. doi: 10.1136/sti.79.3.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vyse A. J., Gay N. J., Slomka M. J., Gopal R., Gibbs T., Morgan-Capner P., Brown D. W. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000 Jun;76(3):183–187. doi: 10.1136/sti.76.3.183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wald Anna, Link Katherine. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2001 Dec 14;185(1):45–52. doi: 10.1086/338231. [DOI] [PubMed] [Google Scholar]
  18. Wasserheit J. N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992 Mar-Apr;19(2):61–77. [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES